SUMO2/3 antibody (AA 1-93)
Quick Overview for SUMO2/3 antibody (AA 1-93) (ABIN7596052)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1-93
-
Purpose
- Human SUMO 2/3 antibody
-
Immunogen
- Recombinant human SUMO2 (1-93aa) purified from E.coli
-
Isotype
- IgG2b kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing cycles
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- SUMO2/3 (Small Ubiquitin Related Modifier 2/3 (SUMO2/3))
-
Alternative Name
- SUMO 2/3
-
Background
- SUMO (small ubiquitin-related modifier) is the best-characterized member of a growing family ofubiquitin-related proteins. 8-11 kDa that covalently modify various intracellular proteins. It resemblesubiquitin in its structure, its ability to be ligated to other proteins. SUMO regulates cellular function of avariety of target proteins. SUMO proteins are expressed as their precursor forms. Cleavage of the residuesafter the GG region of these precursors by SUMO-specific proteases in maturation is a prerequisite forsubsequent sumoylation. Notably, SUMO2 and SUMO3 precursors have 96 % sequence identity, and recentstudies have shown protein substrates conjugated with SUMO2 or SUMO3 have similar, if not identical,biological consequences.
-
NCBI Accession
- NP_008868
Target
-